2016
Incidental injury and repair of obturator nerve during laparoscopic pelvic lymphadenectomy
Menderes G, Vilardo N, Schwab CL, Azodi M. Incidental injury and repair of obturator nerve during laparoscopic pelvic lymphadenectomy. Gynecologic Oncology 2016, 142: 208. PMID: 27234143, DOI: 10.1016/j.ygyno.2016.05.023.Peer-Reviewed Original ResearchConceptsObturator nervePelvic lymphadenectomyTension-free anastomosisIncidental injuryLaparoscopic repairPostoperative day oneLaparoscopic pelvic lymphadenectomyDistal cut endEnd coaptationResidual neuropathyLaparoscopic stagingNeurologic deficitsEndometrial adenocarcinomaGynecologic surgeryLeft thighNeurologic deficiencyAdductor functionLymphadenectomyNerve edgesNerveGynecologic surgeonsFree anastomosisImmediate repairPatientsPolypropylene suture
2015
External Iliac Vein Injury and Repair During Robotic-assisted Pelvic Lymphadenectomy
Menderes G, Clark M, Tower A, Azodi M. External Iliac Vein Injury and Repair During Robotic-assisted Pelvic Lymphadenectomy. Journal Of Minimally Invasive Gynecology 2015, 22: 718. PMID: 25888352, DOI: 10.1016/j.jmig.2015.04.007.Peer-Reviewed Original ResearchMeSH KeywordsFemaleGynecologic Surgical ProceduresHumansHysterectomyIliac VeinLaparoscopyLymph Node ExcisionPelvisRoboticsSuturesConceptsExternal iliac vein injuryIliac vein injuryExternal iliac veinVein injuryPelvic lymphadenectomyIliac veinInsufflation pressureLeft external iliac veinPara-aortic lymphadenectomyPelvic lymphadenectomy proceduresMajor vascular injuryFallopian tube carcinomaBilateral adnexal massesExperienced laparoscopic surgeonsHigh mortality rateBilateral adnexectomySurgical stagingRetroperitoneal lymphadenopathyAbdominal girthImmediate clampingMonopolar scissorsPrimary repairSurgical videosCardiopulmonary statusRobotic hysterectomyComparison of Lymphedema Incidence Between 2 Lymphadenectomy Techniques in Patients With Uterine Cancer Undergoing Robotic Staging
Menderes G, Azodi M, Schwartz P, Silasi DA. Comparison of Lymphedema Incidence Between 2 Lymphadenectomy Techniques in Patients With Uterine Cancer Undergoing Robotic Staging. International Journal Of Gynecological Cancer 2015, 25: 160-165. PMID: 25386859, DOI: 10.1097/igc.0000000000000308.Peer-Reviewed Original ResearchMeSH KeywordsAdenocarcinoma, Clear CellAdultAgedAged, 80 and overCarcinoma, EndometrioidCarcinosarcomaConnecticutCystadenocarcinoma, SerousEndometrial NeoplasmsFemaleFollow-Up StudiesHumansIncidenceLymph Node ExcisionLymph NodesLymphatic MetastasisLymphedemaMiddle AgedNeoplasm StagingPara-Aortic BodiesPelvic NeoplasmsPrognosisRoboticsUterine NeoplasmsConceptsSelective pelvic lymphadenectomyExternal iliac lymph nodesLower extremity lymphedemaStandard pelvic lymphadenectomyIliac lymph nodesPelvic lymphadenectomyLymph nodesLymphadenectomy groupRobotic stagingExtremity lymphedemaUterine cancerPara-aortic lymph nodesPelvic lymphadenectomy groupIncidence of lymphedemaMean operative timePelvic lymph nodesBody mass indexPostoperative hospitalizationSelective lymphadenectomyConsecutive patientsEndometrial cancerEndometrioid adenocarcinomaLymphedema incidenceMass indexOperative time
2014
Impact of Body Mass Index on Surgical Outcomes and Analysis of Disease Recurrence for Patients With Endometrial Cancer Undergoing Robotic-Assisted Staging
Menderes G, Azodi M, Clark L, Xu X, Lu L, Ratner E, Schwartz PE, Rutherford TJ, Santin AD, Silasi DA. Impact of Body Mass Index on Surgical Outcomes and Analysis of Disease Recurrence for Patients With Endometrial Cancer Undergoing Robotic-Assisted Staging. International Journal Of Gynecological Cancer 2014, 24: 1118-1125. PMID: 24927247, DOI: 10.1097/igc.0000000000000156.Peer-Reviewed Original ResearchMeSH KeywordsAdenocarcinoma, Clear CellAdultAgedAged, 80 and overBody Mass IndexCarcinosarcomaCystadenocarcinoma, SerousEndometrial NeoplasmsFemaleFollow-Up StudiesHumansHysterectomyLymph Node ExcisionLymphatic MetastasisMiddle AgedNeoplasm GradingNeoplasm Recurrence, LocalNeoplasm StagingPrognosisRetrospective StudiesRoboticsSurvival RateConceptsBody mass indexRecurrence-free survivalRobotic-assisted stagingEndometrial cancerRecurrence rateDisease recurrenceMass indexMean postoperative hospitalizationLymph node countMean operative timeLong-term outcomesNonendometrioid cancersMorbid obesityPostoperative hospitalizationMetastatic diseaseNonendometrioid histologyObese patientsOverall survivalConsecutive patientsOperative outcomesHistologic subtypeOperative timeSurgical outcomesEndometrioid carcinomaMean age